Janux Therapeutics, Inc. (JANX)

SEC filing

Janux Therapeutics, Inc.

JANX · CIK 1817713

4 · Jan 2, 2026 · Campbell David Alan sold 8,072 shares at $13.73/share ($110.8K); was granted 96.60K shares

Campbell David Alan sold 8,072 shares at $13.73/share ($110.8K); was granted 96.60K shares

xslF345X05/form4-01022026_090108.xml

xslF345X05/form4-01022026_090108.xmlSEC.gov

Graphics and non-inline formats (not embedded below).